Plus Therapeutics, Inc. (PSTV)
6.97
+0.54
(+8.40%)
USD |
NASDAQ |
May 21, 12:26
Plus Therapeutics EPS Diluted (Quarterly) : -1.045 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.2528 |
| AVITA Medical, Inc. | -0.3474 |
| Twist Bioscience Corp. | -0.7134 |
| Elutia, Inc. | -0.1836 |
| TriSalus Life Sciences, Inc. | 0.0294 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.946M |
| Revenue (Quarterly) | 1.028M |
| Total Expenses (Quarterly) | 7.974M |
| Enterprise Value | 29.73M |
| Gross Profit Margin (Quarterly) | 89.40% |
| Profit Margin (Quarterly) | -675.7% |
| Earnings Yield | -46.88% |
| Normalized Earnings Yield | -54.69 |